Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Share-based Compensation (2016 - 2024)

Sunshine Biopharma's Share-based Compensation history spans 9 years, with the latest figure at $12000.0 for Q1 2024.

  • For Q1 2024, Share-based Compensation changed N/A year-over-year to $12000.0; the TTM value through Dec 2024 reached $12000.0, changed N/A, while the annual FY2024 figure was $12000.0, N/A changed from the prior year.
  • Share-based Compensation reached $12000.0 in Q1 2024 per SBFM's latest filing, down from $918000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $918000.0 in Q1 2021 to a low of $12000.0 in Q1 2024.
  • Average Share-based Compensation over 3 years is $326666.7, with a median of $50000.0 recorded in 2020.